Client Result
Orrick Advises Deel in Acquisition of Capbase
1 minute read | January.17.2023
We advised Deel, Inc., a global compliance and payroll solutions platform, in its recent acquisition of Capbase Inc.
Search Results
Client Result
Johnson & Johnson Secures Complete Defense Verdict in Pelvic Mesh Case
January.17.2023
A trial team led by Orrick partner Meghan Kelly secured a complete defense verdict for Johnson & Johnson and its subsidiary, Ethicon, in litigation ...
Client Result
Orrick Advises Chevron New Energies in a Joint Venture with Raven SR and Hyzon Motors to Produce Hydrogen from Green Waste
2 minute read | January.12.2023
Orrick advised Chevron New Energies on its collaboration with Raven SR Inc. and Hyzon Motors Inc. to develop, construct and own a green ...
Client Result
Orrick Advises on Redwood Software’s Acquisition of Tidal Software
1 minute read | January.11.2023
We advised Turn/River Capital on the acquisition by one of its portfolio companies, Redwood Software, of Tidal Software.
Client Result
Orrick Advises the Shareholders of Hueck Group on the Sale to Norsk Hydro
January.10.2023
Orrick advised Hueck Industrie Holding KG as the sole shareholder of Hueck Group on the sale of to the Norwegian aluminum and energy group Norsk ...
Client Result
Orrick Advises Ipsen on Acquisition of Liver Disease Treatment Innovator Albireo
1 minute read | January.09.2023
Orrick is advising Ipsen (Euronext: IPN: ADR: IPSEY) on its acquisition of Albireo Pharma Inc (NASDAQ: ALBO), a leading innovator in bile-acid ...
Client Result
Orrick Advises MTA on Historic Subway Station Accessibility P3
1 minute read | December.30.2022
Orrick’s Infrastructure team advised the Metropolitan Transportation Authority (MTA) on its historic US$965.2 million subway station accessibility P3 ...
Client Result
Orrick Advises MTA on Wireless Connectivity Across All New York City Subway Stations
1 minute read | December.30.2022
The Orrick team advised MTA with the extension of cellular voice and data service throughout the NYC subway system, including cellular connectivity ...
Client Result
Orrick Advises Catalyst Biosciences in Reverse Merger with GNI Group
1 minute read | December.28.2022
Orrick advised South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. in its acquisition of the F351 program, a ...
Client Result
Orrick Advises on US$2.4 Billion PennDOT Pathways Major Bridge P3 Program
December.27.2022
Orrick advised Bridging Pennsylvania Developer I, a consortium comprised of Macquarie Capital and Shikun & Binui USA, as borrowers counsel for the ...
Client Result
Orrick Advises Kistos Holdings on its AIM Direct Listing
December.27.2022
Orrick advised Kistos Holdings plc (LSE: KIST), a low carbon intensity gas producer pursuing energy opportunities in line with the energy transition.
Client Result
Orrick Advises Fuwei Films on Its Merger With BaiJiaYun
December.27.2022
Orrick advised Fuwei Films (Holdings) Co., Ltd. (Nasdaq: FFHL) on its merger with with BaiJiaYun Limited.